{"_id": "5334825138f0d8100c38ef65", "print_page": null, "blog": [], "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS"}, "multimedia": [], "source": "AP", "type_of_material": "News", "news_desk": null, "snippet": "A panel of Food and Drug Administration advisers has voted to endorse an experimental stool test that uses DNA to detect colon cancer and precancerous growths....", "document_type": "article", "subsection_name": null, "word_count": "400", "headline": {"print_headline": "FDA Advisers Back Exact Sciences Colon Cancer Test", "main": "FDA Advisers Back Exact Sciences Colon Cancer Test"}, "lead_paragraph": "A panel of Food and Drug Administration advisers has voted to endorse an experimental stool test that uses DNA to detect colon cancer and precancerous growths.", "slideshow_credits": null, "keywords": [], "pub_date": "2014-03-27T15:55:33Z", "section_name": "Business Day", "abstract": null, "web_url": "http://www.nytimes.com/aponline/2014/03/27/business/ap-us-colon-cancer-dna-test.html"}